Clinical Trial Update: MMF for HIV Reservoir Reduction [Phase 2]

View source ↗

Summary

Phase 2 trial investigating mycophenolate mofetil (MMF) for HIV reservoir reduction in people with HIV infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MMF (mycophenolate mofetil)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Human Immunodeficiency Virus I Infection | Phase 2 | Status: COMPLETED | Results posted: 2020-12-03